www.fdanews.com/articles/198896-fda-gives-emergency-clearance-to-roches-covid-19influenza-test
![emergency use authorization approved](https://www.fdanews.com/ext/resources/test/Drug-Images4/emergency-use-authorization-EUA-approved.gif?t=1586211479&width=430)
FDA Gives Emergency Clearance to Roche’s COVID-19/Influenza Test
September 8, 2020
Roche has received an Emergency Use Authorization from the FDA for its SARS-CoV-2 and influenza A&B test.
The diagnostic is used on Roche’s cobas 6800 and 8800 systems and is designed for high-volume testing, providing up to 96 test results in approximately three hours.
The product is the first commercial test for automated high-throughput systems that can identify and differentiate between SARS-CoV-2, influenza A and influenza B using a single sample, according to the company.